The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
Our Dean Morten Dæhlen visited Brazil and PharmaTox partners
Nov. 22, 2017 11:10 AM
PharmaTox PhD student at the 14th National Stem Cell Networking Conference
Nov. 2, 2017 3:52 PM
PharmaTox PhD student Martin Falck recently atttended the 14th National Stem Cell Networking Conference. He presented his work on in vitro studies using human embryonic stem cells to find out more on the biology behind the connection between prenatal exposure of paracetamol and risk of developing ADHD.
Paracetamol for pregnant women: short term use can protect the fetus
Oct. 31, 2017 9:06 AM
Eivind Ystrøm and Hedvig Nordeng are interviewed in Titan.no, forskning.no and fhi.no regarding the new article "Prenatal exposure to Acetaminophen and risk of ADHD"
Kristina and Robert in Titan
Oct. 25, 2017 11:17 AM
Kristina Gervin and Robert Lyle have been interviewed by Titan concering the article: Long-term prenatal exposure to paracetamol is associated with DNA methylation differences in children diagnosed with ADHD.
PharmaSafe guest lecture Oct. 23: Fetal effects of maternal drug treatment - risk assessment and communication
Oct. 12, 2017 9:01 AM
Ulrika Nörby will give a lecture on: Fetal effects of maternal drug treatment - risk assessment and communication